Cleaved Fragments Prediction Algorithm (CFPA) application to calpain and caspase in apoptosis and necrotic cell death

The activation of cysteine proteases, calpain and caspase-3, which orchestrate the two major types of cell death, necrosis and apoptosis in various neurological and neurodegenerative disorders, drive cleavage of susceptible cellular proteins whose Breakdown Products (BDPs) can be utilized as biochemical markers; these markers can distinguish the molecular root causes among different types of neural cell death. There is an immense need to make such distinction between calpain and caspase-dependant dominated types of cell injury which is crucial in order to identify the injury mechanisms; thus, creating opportunities for neurotherapy development. Calpain protease is activated in various necrotic and apoptotic conditions generating calpain-specific cleaved fragments, while caspase-3 is predominantly activated in neuronal apoptosis generating caspase-3-specific cleaved fragments. Yet, despite the difference in cleavage specificity between calpain and caspase, some cellular proteins are dually susceptible to both proteases in some neurotoxic challenges such as hypoxia-hypoglycemia and excitotoxin treatment. During their activation, it is difficult to identify the resulting fragments despite the advanced experimental proteomics techniques in the field of degradomics. Current approaches rely on experimental techniques involving western blotting technique coupled with protein sequencing to identify the sequence specific and fragmentation site of the specific BDP(s). The main purpose of this work is to establish a new efficient and accurate methodological tool based on dynamic programming to predict those BDPs computationally with an algorithm of space complexity O(mn) and time complexity O(NN'mn), where the comprised parameters correspond to number of protein sequences, number of consensus sequences, length of each protein sequence, and length of each consensus sequence, respectively. The current algorithm is based on a modification of the Cleaved Fragments Prediction Algorithm (CFPA) and achieves high homology with experimental results.

[1]  B. Bahr,et al.  The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states , 2000, International journal of experimental pathology.

[2]  R. Hayes,et al.  Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways , 2009, Apoptosis.

[3]  C. Thompson,et al.  The central effectors of cell death in the immune system. , 1999, Annual review of immunology.

[4]  C. López-Otín,et al.  Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.

[5]  R. Hayes,et al.  A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. , 2004, Journal of neurotrauma.

[6]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[7]  M. Prevost,et al.  Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. , 2001, Cytometry.

[8]  J. Povlishock,et al.  Traumatically Induced Axonal Injury: Pathogenesis and Pathobiological Implications , 1991, Brain pathology.

[9]  F. Tortella,et al.  Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.

[10]  Kevin K W Wang,et al.  Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. , 2002, Biological chemistry.

[11]  Simon C Watkins,et al.  Apoptosis-Suppressor Gene bcl-2 Expression after Traumatic Brain Injury in Rats , 1997, The Journal of Neuroscience.

[12]  D. Graham,et al.  Apoptosis after traumatic brain injury. , 2000, Journal of neurotrauma.

[13]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[14]  W. Van den Broeck,et al.  Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis , 2002, Anatomia, histologia, embryologia.

[15]  B. Pike,et al.  Temporal Profile and Cell Subtype Distribution of Activated Caspase‐3 Following Experimental Traumatic Brain Injury , 2000, Journal of neurochemistry.

[16]  G. Kroemer,et al.  The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death , 1997, Oncogene.

[17]  B. Pike,et al.  Temporal relationships between de novo protein synthesis, calpain and caspase 3‐like protease activation, and DNA fragmentation during apoptosis in septo‐hippocampal cultures , 1998, Journal of neuroscience research.

[18]  R. Talanian,et al.  Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells* , 1998, The Journal of Biological Chemistry.

[19]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[20]  K. Wang,et al.  CALPAIN INHIBITORS : NOVEL NEUROPROTECTANTS AND POTENTIAL ANTI CATARACT AGENTS , 1998 .

[21]  N. Hayashi,et al.  Traumatic Axonal Injury , 2004 .

[22]  R. Hayes,et al.  Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. , 2007, Journal of neurosurgery.

[23]  S. Lipton,et al.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Jang Hwan Kim Book Review: Fundamentals of Clinical Trials. 4th ed. , 2013, International Neurourology Journal.

[25]  B. Pike,et al.  Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury , 1998, Neuroreport.

[26]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[27]  F. Tortella,et al.  Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  K. Raser,et al.  Effects of ICE‐like protease and calpain inhibitors on neuronal apoptosis , 1996, Neuroreport.

[29]  H. Lassmann,et al.  Ischemia Leads to Apoptosis—and Necrosis‐like Neuron Death in the Ischemic Rat Hippocampus , 2004, Brain pathology.

[30]  C. Behl,et al.  Apoptosis and Alzheimer's disease , 2000, Journal of Neural Transmission.

[31]  R. Hayes,et al.  Novel neuroproteomic approaches to studying traumatic brain injury. , 2007, Progress in brain research.

[32]  K. Wang,et al.  Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. , 2000, Biochemical and biophysical research communications.

[33]  M Jaffar,et al.  Calcium signalling and pancreatic cell death: apoptosis or necrosis? , 2007, Cell Death and Differentiation.

[34]  A. Malkinson,et al.  Calpain activation in apoptosis , 1994, Journal of cellular physiology.

[35]  Zaher Dawy,et al.  Efficient and Accurate Algorithm for Cleaved Fragments Prediction (CFPA) in Protein Sequences Dataset Based on Consensus and Its Variants: A Novel Degradomics Prediction Application. , 2017, Methods in molecular biology.

[36]  Jeremy J. Flint,et al.  Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats , 2001 .

[37]  M S Waterman,et al.  Identification of common molecular subsequences. , 1981, Journal of molecular biology.

[38]  E Farber,et al.  Programmed cell death: necrosis versus apoptosis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[39]  S. Levin Apoptosis, necrosis, or oncosis: what is your diagnosis? A report from the Cell Death Nomenclature Committee of the Society of Toxicologic Pathologists. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  Kevin K W Wang,et al.  Evidence for Activation of Caspase‐3‐Like Protease in Excitotoxin‐ and Hypoxia/Hypoglycemia‐Injured Neurons , 1998, Journal of neurochemistry.

[41]  R. Gilbertsen,et al.  Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. , 1996, The Biochemical journal.

[42]  Peter J. Kirkpatrick,et al.  Head trauma: basic, preclinical, and clinical directions , 2002 .